Motor Neuron Biology and Disease: A Current Perspective on Infantile-Onset Spinal Muscular Atrophy

References

• Sugarman EA , NaganN, ZhuHet al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur. J. Hum. Genet.20(1), 27–32 (2012).
   PubMed Web of Science ®Google Scholar
• Hendrickson BC , DonohoeC, AkmaevVRet al. Differences in SMN1 allele frequencies among ethnic groups within North America. J. Med Genet.46(9), 641–644 (2009).
   PubMed Web of Science ®Google Scholar
• Wang CH , LunnMR. Spinal muscular atrophy: advances in research and consensus on care of patients. Curr. Treat. Options Neurol.10(6), 420–428 (2008).
   PubMedGoogle Scholar
• Grotto S , CuissetJM, MarretSet al. Type 0 spinal muscular atrophy: further delineation of prenatal and postnatal features in 16 patients. J. Neuromuscul. Dis.3(4), 487–495 (2016).
   PubMedGoogle Scholar
• Clermont O , BurletP, LefebvreSet al. SMN gene deletions in adult-onset spinal muscular atrophy. Lancet346(8991–8992), 1712–1713 (1995).
   PubMed Web of Science ®Google Scholar
• Kline RA , KaiferKA, OsmanEYet al. Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases. PLoS Genet.13(3), e1006680 (2017).
   PubMed Web of Science ®Google Scholar
• Boyd PJ , TuWY, ShorrockHKet al. Bioenergetic status modulates motor neuron vulnerability and pathogenesis in a zebrafish model of spinal muscular atrophy. PLoS Genet.13(4), e1006744 (2017).
   PubMed Web of Science ®Google Scholar
• Boyer JG , MurrayLM, ScottK, De RepentignyY, RenaudJM, Kothary. Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy. Skelet. Muscle3(1), 24 (2013).
   PubMedGoogle Scholar
• Bowerman M , SwobodaKJ, MichalskiJPet al. Glucose metabolism and pancreatic defects in spinal muscular atrophy. Ann. Neurol.72(2), 256–268 (2012).
   PubMed Web of Science ®Google Scholar
• Bowerman M , MichalskiJP, BeauvaisA, MurrayLM, DeRepentignyY, KotharyR. Defects in pancreatic development and glucose metabolism in SMN-depleted mice independent of canonical spinal muscular atrophy neuromuscular pathology. Hum. Mol. Genet.23(13), 3432–3444 (2014).
   PubMed Web of Science ®Google Scholar
• Deguise MO , KotharyR. New insights into SMA pathogenesis: immune dysfunction and neuroinflammation. Ann. Clin. Transl. Neurol.4(7), 522–530 (2017).
   PubMed Web of Science ®Google Scholar
• Somers E , StencelZ, WishartTM, GillingwaterTH, ParsonSH. Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy. Neuromuscul. Disord.22(5), 435–442 (2012).
   PubMed Web of Science ®Google Scholar
• Hunter G , Aghamaleky SarvestanyA, RocheSL, SymesRC, GillingwaterTH. SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy. Hum. Mol. Genet.23(9), 2235–2250 (2014).
   PubMed Web of Science ®Google Scholar
• Rindt H , FengZ, MazzasetteC, GlascockJJet al. Astrocytes influence the severity of spinal muscular atrophy. Hum. Mol. Genet.24(14), 4094–4102 (2015).
   PubMed Web of Science ®Google Scholar
• Werdnig G . Zwei frühinfantile hereditäre Fälle von progressiver Muskelatrophie unter dem Bilde der Dystrophie, aber auf neurotischer Grundlage. Arch. Psychiat. Nervenkr.22, 437–480 (1891).
   Google Scholar
• Hoffmann J . Ueber chronische spinale Muskelatrophie im Kindesalter, auf familiärer Basis. Deutsch Z Nervenheilk3, 427–470 (1893).
   Google Scholar
• Hoffmann J . Weiterer Beitrag zur Lehre von der hereditären progressiven spinalen Muskelatrophie im Kindesalter nebst Bemerkungen über den fortschreitenden Muskelschwund im Allgemeinen. Deutsch Z Nervenheilk10, 292–320 (1897).
   Google Scholar
• Hoffmann J . Dritter Beitrag zur Lehre von der hereditären progressiven spinalen Muskelatrophie im Kindesalter. Deutsch Z Nervenheilk18, 217–224 (1900).
   Google Scholar
• Lefebvre S , BurglenL, ReboulletSet al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell80(1), 155–165 (1995).
   PubMed Web of Science ®Google Scholar
• Rochette CF , GilbertN, SimardLR. SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens. Hum. Genet.108(3), 255–266 (2001).
   PubMed Web of Science ®Google Scholar
• Monani UR , LorsonCL, ParsonsDWet al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet.8(7), 1177–1183 (1999).
   PubMed Web of Science ®Google Scholar
• Lorson CL , HahnenE, AndrophyEJ, WirthB. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl Acad. Sci. USA96(11), 6307–6311 (1999).
   PubMed Web of Science ®Google Scholar
• Kashima T , ManleyJL. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat. Genet.34(4), 460–463 (2003).
   PubMed Web of Science ®Google Scholar
• Cho S , DreyfussG. A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev.24(5), 438–442 (2010).
   PubMed Web of Science ®Google Scholar
• Coovert DD , LeTT, McAndrewPEet al. The survival motor neuron protein in spinal muscular atrophy. Hum. Mol. Genet.6(8), 1205–1214 (1997).
   PubMed Web of Science ®Google Scholar
• Lefebvre S , BurletP, LiuQet al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet.16(3), 265–269 (1997).
   PubMed Web of Science ®Google Scholar
• McAndrew PE , ParsonsDW, SimardLRet al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am. J. Hum Genet.60(6), 1411–22 (1997).
   PubMed Web of Science ®Google Scholar
• Feldkotter M , SchwarzerV, WirthR, WienkerTF, WirthB. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am. J. Hum. Genet.70(2), 358–368 (2002).
   PubMed Web of Science ®Google Scholar
• Prior TW , KrainerAR, HuaYet al. A positive modifier of spinal muscular atrophy in the SMN2 gene. Am. J. Hum. Genet.85(3), 408–413 (2009).
   PubMed Web of Science ®Google Scholar
• Wu X , WangSH, SunJ, KrainerAR, HuaY, PriorTW. A-44G transition in SMN2 intron 6 protects patients with spinal muscular atrophy. Hum. Mol. Genet.26(14), 2768–2780 (2017).
   PubMed Web of Science ®Google Scholar
• Liu Q , DreyfussG. A novel nuclear structure containing the survival of motor neurons protein. EMBO J.15(14), 3555–3565 (1996).
   PubMed Web of Science ®Google Scholar
• Young PJ , LeTT, thi ManN, BurghesAH, MorrisGE. The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells. Exp. Cell Res.256(2), 365–374 (2000).
   PubMed Web of Science ®Google Scholar
• Liu Q , FischerU, WangF, DreyfussG. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell90(6), 1013–1021 (1997).
   PubMed Web of Science ®Google Scholar
• Fischer U , LiuQ, DreyfussG. The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell90(6), 1023–1029 (1997).
   PubMed Web of Science ®Google Scholar
• Pellizzoni L , KataokaN, CharrouxB, DreyfussG. A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell95(5), 615–624 (1998).
   PubMed Web of Science ®Google Scholar
• Chari A , PakniaE, FischerU. The role of RNP biogenesis in spinal muscular atrophy. Curr. Opin. Cell Biol.21(3), 387–393 (2009).
   PubMed Web of Science ®Google Scholar
• Grimmler M , OtterS, PeterC, MüllerF, ChariA, FischerU. Unrip, a factor implicated in cap-independent translation, associates with the cytosolic SMN complex and influences its intracellular localization. Hum. Mol. Genet.14(20), 3099–3111 (2005).
   PubMed Web of Science ®Google Scholar
• Chari A , GolasMM, KlingenhägerMet al. An assembly chaperone collaborates with the SMN complex to generate spliceosomal SnRNPs. Cell135(3), 497–509 (2008).
   PubMed Web of Science ®Google Scholar
• Narayanan U , OspinaJK, FreyMR, HebertMD, MateraAG. SMN, the spinal muscular atrophy protein, forms a pre-import snRNP complex with snurportin1 and importin beta. Hum. Mol. Genet.11(15), 1785–1795 (2002).
   PubMed Web of Science ®Google Scholar
• Narayanan U , AchselT, LührmannR, MateraAG. Coupled in vitro import of U snRNPs and SMN, the spinal muscular atrophy protein. Mol. Cell16(2), 223–234 (2004).
   PubMed Web of Science ®Google Scholar
• Schrank B , GötzR, GunnersenJMet al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl Acad. Sci. USA94(18), 9920–9925 (1997).
   PubMed Web of Science ®Google Scholar
• Jablonka S , HoltmannB, MeisterGet al. Gene targeting of Gemin2 in mice reveals a correlation between defects in the biogenesis of U snRNPs and motoneuron cell death. Proc. Natl Acad. Sci. USA99(15), 10126–10131 (2002).
   PubMed Web of Science ®Google Scholar
• Mouillet JF , YanX, OuQet al. DEAD-box protein-103 (DP103, Ddx20) is essential for early embryonic development and modulates ovarian morphology and function. Endocrinology149(5), 2168–2175 (2008).
   PubMed Web of Science ®Google Scholar
• Shpargel KB , PraveenK, RajendraTK, MateraAG. Gemin3 is an essential gene required for larval motor function and pupation in Drosophila. Mol. Biol. Cell20(1), 90–101 (2009).
   PubMed Web of Science ®Google Scholar
• Meier ID , WalkerMP, MateraAG. Gemin4 is an essential gene in mice, and its overexpression in human cells causes relocalization of the SMN complex to the nucleoplasm. Biol. Open7(2), pii: bio032409 (2018).
   PubMed Web of Science ®Google Scholar
• Gates J , LamG, OrtizJA, LossonR, ThummelCS. rigor mortis encodes a novel nuclear receptor interacting protein required for ecdysone signaling during Drosophila larval development. Development131(1), 25–36 (2004).
   PubMed Web of Science ®Google Scholar
• Wan L , BattleDJ, YongJet al. The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy. Mol. Cell. Biol.25(13), 5543–5551 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang Z , LottiF, DittmarKet al. SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell133(4), 585–600 (2008).
   PubMed Web of Science ®Google Scholar
• Kim JK , CaineC, AwanoT, HerbstR, MonaniUR. Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice. Hum. Mol. Genet.26(13), 2377–2385 (2017).
   PubMed Web of Science ®Google Scholar
• Lotti F , ImlachWL, SaievaLet al. An SMN-dependent U12 splicing event essential for motor circuit function. Cell151(2), 440–454 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang Z , PintoAM, WanLet al. Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy. Proc. Natl Acad. Sci. USA110(48), 19348–19353 (2013).
   PubMed Web of Science ®Google Scholar
• Workman E , SaievaL, CarrelTLet al. A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice. Hum. Mol. Genet.18(12), 2215–2229 (2009).
   PubMed Web of Science ®Google Scholar
• Gabanella F , ButchbachME, SaievaL, CarissimiC, BurghesAH, PellizzoniL. Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs. PLoS One2(9), e921 (2007).
   PubMed Web of Science ®Google Scholar
• Ruggiu M , McGovernVL, LottiFet al. A role for SMN exon 7 splicing in the selective vulnerability of motor neurons in spinal muscular atrophy. Mol. Cell. Biol.32(1), 126–38 (2012).
   PubMed Web of Science ®Google Scholar
• Jodelka FM , EbertAD, DuelliDM, HastingsML. A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2. Hum. Mol. Genet.19(24), 4906–4917 (2010).
   PubMed Web of Science ®Google Scholar
• Comley LH , NijssenJ, Frost-NylenJ, HedlundE. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology. J. Comp. Neurol.524(7), 1424–1442 (2016).
   PubMed Web of Science ®Google Scholar
• Steiman GS , RorkeLB, BrownMJ. Infantile neuronal degeneration masquerading as Werdnig-Hoffmann disease. Ann. Neurol.8(3), 317–324 (1980).
   PubMed Web of Science ®Google Scholar
• Wishart TM , MutsaersCA, RiesslandMet al. Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy. J. Clin. Invest.124(4), 1821–1834 (2014).
   PubMed Web of Science ®Google Scholar
• Ripolone M , RonchiD, ViolanoRet al. Impaired muscle mitochondrial biogenesis and myogenesis in spinal muscular atrophy. JAMA Neurol.72(6), 666–675 (2015).
   PubMed Web of Science ®Google Scholar
• Sanchez G , DuryAY, MurrayLMet al. A novel function for the survival motoneuron protein as a translational regulator. Hum. Mol. Genet.22(4), 668–684 (2013).
   PubMed Web of Science ®Google Scholar
• Strasswimmer J , LorsonCL, BreidingDEet al. Identification of survival motor neuron as a transcriptional activator-binding protein. Hum. Mol. Genet.8(7), 1219–1226 (1999).
   PubMed Web of Science ®Google Scholar
• Rossoll W , KröningAK, OhndorfUM, SteegbornC, JablonkaS, SendtnerM. Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?Hum. Mol. Genet.11(1), 93–105 (2002).
   PubMed Web of Science ®Google Scholar
• McWhorter ML , MonaniUR, BurghesAH, BeattieCE. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol.162(5), 919–931 (2003).
   PubMed Web of Science ®Google Scholar
• Kariya S , MauricioR, DaiY, MonaniUR. The neuroprotective factor Wld(s) fails to mitigate distal axonal and neuromuscular junction (NMJ) defects in mouse models of spinal muscular atrophy. Neurosci. Lett.449(3), 246–251 (2009).
   PubMed Web of Science ®Google Scholar
• Murray LM , ComleyLH, ThomsonD, ParkinsonN, TalbotK, GillingwaterTH. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet.17(7), 949–962 (2008).
   PubMed Web of Science ®Google Scholar
• Ling KK , LinMY, ZinggB, FengZ, KoCP. Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy. PLoS One5(11), e15457 (2010).
   PubMed Web of Science ®Google Scholar
• Kariya S , ParkGH, Maeno-HikichiYet al. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum. Mol. Genet.17(16), 2552–2569 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang H , XingL, RossollW, WichterleH, SingerRH, BassellGJ. Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons. J. Neurosci.26(33), 8622–8632 (2006).
   PubMed Web of Science ®Google Scholar
• Rossoll W , KröningAK, OhndorfUM, SteegbornC, JablonkaS, SendtnerM. Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?Hum. Mol. Genet.11(1), 93–105 (2002).
   PubMed Web of Science ®Google Scholar
• Akten B , KyeMJ, Hao leTet al. Interaction of survival of motor neuron (SMN) and HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits. Proc. Natl Acad. Sci. USA108(25), 10337–10342 (2011).
   PubMed Web of Science ®Google Scholar
• Tadesse H , Deschênes-FurryJ, BoisvenueS, CôtéJ. KH-type splicing regulatory protein interacts with survival motor neuron protein and is misregulated in spinal muscular atrophy. Hum. Mol. Genet.17(4), 506–524 (2008).
   PubMed Web of Science ®Google Scholar
• Hubers L , Valderrama-CarvajalH, LaframboiseJ, TimbersJ, SanchezG, CôtéJ. HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects. Hum. Mol. Genet.20(3), 553–579 (2011).
   PubMed Web of Science ®Google Scholar
• Mobarak CD , AndersonKD, MorinMet al. The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells. Mol. Biol. Cell11(9), 3191–3203 (2000).
   PubMed Web of Science ®Google Scholar
• Aranda-Abreu GE , BeharL, ChungS, FurneauxH, GinzburgI. Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cells. J. Neurosci.19(16), 6907–6917 (1999).
   PubMed Web of Science ®Google Scholar
• Deschênes-Furry J , MousaviK, BolognaniFet al. The RNA-binding protein HuD binds acetylcholinesterase mRNA in neurons and regulates its expression after axotomy. J. Neurosci.27(3), 665–675 (2007).
   PubMed Web of Science ®Google Scholar
• Fallini C , Donlin-AspPG, RouanetJP, BassellGJ, RossollW. Dynamics of survival of motor neuron (SMN) protein interaction with the mRNA-binding protein IMP1 facilitates its trafficking into motor neuron axons. J. Neurosci.36(13), 3811–3820 (2016).
   PubMed Web of Science ®Google Scholar
• Hao le T , DuyPQ, AnMet al. HuD and the survival motor neuron protein interact in motoneurons and are essential for motoneuron development, function, and mRNA Regulation. J. Neurosci.37(48), 11559–11571 (2017).
   PubMed Web of Science ®Google Scholar
• Wirth B , TessaroloD, HahnenEet al. Different entities of proximal spinal muscular atrophy within one family. Hum. Genet.100(5–6), 676–680 (1997).
   PubMed Web of Science ®Google Scholar
• Oprea GE , KröberS, McWhorterMLet al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science320(5875), 524–527 (2008).
   PubMed Web of Science ®Google Scholar
• Hosseinibarkooie S , PetersM, Torres-BenitoLet al. The power of human protective modifiers: PLS3 and CORO1C unravel impaired endocytosis in spinal muscular atrophy and rescue SMA phenotype. Am. J. Hum. Genet.99(3), 647–665 (2016).
   PubMed Web of Science ®Google Scholar
• Riessland M , KaczmarekA, SchneiderSet al. Neurocalcin delta suppression protects against spinal muscular atrophy in humans and across species by restoring impaired endocytosis. Am. J. Hum. Genet.100(2), 297–315 (2017).
   PubMed Web of Science ®Google Scholar
• Torres-Benito L , NeherMF, CanoR, RuizR, TabaresL. SMN requirement for synaptic vesicle, active zone and microtubule postnatal organization in motor nerve terminals. PLoS One6(10), e26164 (2011).
   PubMed Web of Science ®Google Scholar
• Tejero R , Lopez-ManzanedaM, ArumugamS, TabaresL. Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in spinal muscular atrophy. Hum. Mol. Genet.25(21), 4703–4716 (2016).
   PubMed Web of Science ®Google Scholar
• Bowerman M , AndersonCL, BeauvaisA, BoylPP, WitkeW, KotharyR. SMN, profilin IIa and plastin 3: a link between the deregulation of actin dynamics and SMA pathogenesis. Mol. Cell. Neurosci.42(1), 66–74 (2009).
   PubMed Web of Science ®Google Scholar
• Hensel N , ClausP. The actin cytoskeleton in SMA and ALS: how does it contribute to motoneuron degeneration?Neuroscientist24(1), 54–72 (2018).
   PubMed Web of Science ®Google Scholar
• Bowerman M , BeauvaisA, AndersonCL, KotharyR. Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model. Hum. Mol. Genet.19(8), 1468–1478 (2010).
   PubMed Web of Science ®Google Scholar
• Bowerman M , MurrayLM, BoyerJG, AndersonCL, KotharyR. Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy. BMC Med.10, 24 (2012).
   PubMed Web of Science ®Google Scholar
• Hamilton G , GillingwaterTH. Spinal muscular atrophy: going beyond the motor neuron. Trends Mol. Med.19(1), 40–50 (2013).
   PubMed Web of Science ®Google Scholar
• Nash LA , BurnsJK, ChardonJW, KotharyR, ParksRJ. Spinal muscular atrophy: more than a disease of motor neurons?Curr. Mol. Med.16(9), 779–792 (2016).
   PubMed Web of Science ®Google Scholar
• Gavrilina TO , McGovernVL, WorkmanEet al. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect. Hum. Mol. Genet.17(8), 1063–1075 (2008).
   PubMed Web of Science ®Google Scholar
• Iyer CC , McGovernVL, MurrayJDet al. Low levels of Survival Motor Neuron protein are sufficient for normal muscle function in the SMNΔ7 mouse model of SMA. Hum. Mol. Genet.24(21), 6160–6173 (2015).
   PubMed Web of Science ®Google Scholar
• Martinez TL , KongL, WangXet al. Survival Motor Neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy. J. Neurosci.32(25), 8703–8715 (2012).
   PubMed Web of Science ®Google Scholar
• Monani UR , SendtnerM, CoovertDDet al. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn (-/-) mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet.9(3), 333–339 (2000).
   PubMed Web of Science ®Google Scholar
• Hsieh-Li HM , ChangJG, JongYJet al. (2000) A mouse model for spinal muscular atrophy. Nat. Genet.24(1), 66–70 (2007).
   Google Scholar
• Singh NK , SinghNN, AndrophyEJ, SinghRN. Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron. Mol. Cell. Biol.26(4), 1333–1346 (2006).
   PubMed Web of Science ®Google Scholar
• Hua Y , SahashiK, HungGet al. Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am. J. Hum. Genet.82(4), 834–848 (2008).
   PubMed Web of Science ®Google Scholar
• Kim JK , MonaniUR. Augmenting the SMN protein to treat infantile spinal muscular atrophy. Neuron97(5), 1001–1003 (2018).
   PubMed Web of Science ®Google Scholar
• Finkel RS , MercuriE, DarrasBTet al. Nusinersen versus Sham control in infantile-onset spinal muscular atrophy. N. Engl. J. Med.377(18), 1723–1732 (2017).
   PubMed Web of Science ®Google Scholar
• https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm534611.htm.
   Google Scholar
• Foust KD , NurreE, MontgomeryCL, HernandezA, ChanCM, KasparBK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol.27(1), 59–65 (2009).
   PubMed Web of Science ®Google Scholar
• Bucher T , ColleMA, WakelingEet al. scAAV9 intracisternal delivery results in efficient gene transfer to the central nervous system of a feline model of motor neuron disease. Hum. Gene Ther.24(7), 670–82 (2013).
   PubMed Web of Science ®Google Scholar
• Foust KD , WangX, McGovernVLet al. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat. Biotech.28(3), 271–274 (2010).
   PubMed Web of Science ®Google Scholar
• Duque SI , ArnoldWD, OdermattPet al. A large animal model of spinal muscular atrophy and correction of phenotype. Ann. Neurol.77(3), 399–414 (2015).
   PubMed Web of Science ®Google Scholar
• Mendell JR , Al-ZaidyS, ShellRet al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med.377(18), 1713–1722 (2017).
   PubMed Web of Science ®Google Scholar
• Bordet T , BernaP, AbitbolJL, PrussRM. Olesoxime (TRO19622): a novel mitochondrial-targeted neuroprotective compound. Pharmaceuticals (Basel).3(2), 345–368 (2010).
   PubMedGoogle Scholar
• Bertini E , DessaudE, MercuriEet al. Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled Phase 2 trial. Lancet Neurol.16(7), 513–522 (2017).
   PubMed Web of Science ®Google Scholar
• Andrews JA , MillerTM, VijayakumarVet al. CK-2127107 amplifies skeletal muscle response to nerve activation in humans. Muscle Nerve57(5), 729–734 (2017).
   PubMed Web of Science ®Google Scholar
• Andrews JA , CudkowiczME, HardimanOet al. VITALITY-ALS, a Phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics. Amyotroph. Lateral Scler. Frontotemporal Degener.19(3–4), 259–266 (2018).
   PubMed Web of Science ®Google Scholar
• Lutz CM , KariyaS, PatruniSet al. Post-symptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy. J. Clin. Invest.121(8), 3029–3041 (2011).
   PubMed Web of Science ®Google Scholar
• Kariya S , ObisT, GaroneCet al. Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation. J. Clin. Invest.124(2), 785–800 (2014).
   PubMed Web of Science ®Google Scholar
• Mercuri E , DarrasBT, ChiribogaCAet al. Nusinersen versus sham control in later-onset spinal muscular atrophy. N. Engl. J. Med.378(7), 625–635 (2018).
   PubMed Web of Science ®Google Scholar
• van der Ploeg AT . The dilemma of two innovative therapies for spinal muscular atrophy. N. Engl. J. Med.377(18), 1786–1787 (2017).
   PubMed Web of Science ®Google Scholar